Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

NCT00793195 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome
Intestinal Failure
Gastrointestinal Motility Disorder
Mucosal Enteropathy

Interventions

DRUG: Intralipid 20%
DRUG: SMOFlipid 20%

Sponsor

The Hospital for Sick Children

Collaborators

[object Object]